BR0101280A - Processo para a preparação de piridinas substituìdas - Google Patents

Processo para a preparação de piridinas substituìdas

Info

Publication number
BR0101280A
BR0101280A BR0101280-0A BR0101280A BR0101280A BR 0101280 A BR0101280 A BR 0101280A BR 0101280 A BR0101280 A BR 0101280A BR 0101280 A BR0101280 A BR 0101280A
Authority
BR
Brazil
Prior art keywords
preparation
substituted pyridines
pyridines
substituted
synthesis
Prior art date
Application number
BR0101280-0A
Other languages
English (en)
Inventor
Steven Roy Schneider
Robert Lee Dow
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0101280A publication Critical patent/BR0101280A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA A PREPARAçãO DE PIRIDINAS SUBSTITUìDAS". Um processo para a preparação de um composto da fórmula em que n, R^ 1^, R^ 2^, R^ 3^ e X são conforme anteriormente definidos, usado como intermediário na síntese de agonistas do receptor <225>-adrenérgico.
BR0101280-0A 2000-03-31 2001-03-30 Processo para a preparação de piridinas substituìdas BR0101280A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19377200P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
BR0101280A true BR0101280A (pt) 2001-11-06

Family

ID=22714938

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0101280-0A BR0101280A (pt) 2000-03-31 2001-03-30 Processo para a preparação de piridinas substituìdas

Country Status (25)

Country Link
US (4) US6518431B2 (pt)
EP (1) EP1138685B1 (pt)
JP (1) JP2001316393A (pt)
KR (2) KR100435128B1 (pt)
CN (1) CN1191235C (pt)
AR (1) AR033812A1 (pt)
AT (1) ATE267204T1 (pt)
AU (1) AU782272B2 (pt)
BR (1) BR0101280A (pt)
CA (1) CA2342571A1 (pt)
CZ (1) CZ20011194A3 (pt)
DE (1) DE60103317T2 (pt)
DK (1) DK1138685T3 (pt)
ES (1) ES2217090T3 (pt)
HU (1) HUP0101332A3 (pt)
ID (1) ID29728A (pt)
MX (1) MXPA01003383A (pt)
PL (1) PL346805A1 (pt)
PT (1) PT1138685E (pt)
RU (1) RU2223956C2 (pt)
SI (1) SI1138685T1 (pt)
TR (1) TR200401359T4 (pt)
TW (1) TW555761B (pt)
YU (1) YU23301A (pt)
ZA (1) ZA200102538B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190122333A (ko) 2018-04-20 2019-10-30 사단법인 한국지능형교통체계협회 스터드 레일 피팅
KR102037602B1 (ko) 2018-04-20 2019-10-28 사단법인 한국지능형교통체계협회 저상 버스용 고정 바를 갖춘 휠체어 잠금장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
CA2257206A1 (en) * 1996-06-07 1997-12-11 Gui-Bai Liang Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
US5792871A (en) 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
KR20000070568A (ko) * 1997-01-28 2000-11-25 폴락 돈나 엘. 당뇨병 및 비만 치료를 위한 β3 효능제로서의 티아졸 벤젠설폰아미드
HUP0200092A3 (en) * 1999-02-16 2003-02-28 Kaneka Corp Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same

Also Published As

Publication number Publication date
ES2217090T3 (es) 2004-11-01
EP1138685A2 (en) 2001-10-04
PT1138685E (pt) 2004-08-31
KR20030072295A (ko) 2003-09-13
MXPA01003383A (es) 2005-08-26
CN1191235C (zh) 2005-03-02
HUP0101332A2 (en) 2002-10-28
KR20010095192A (ko) 2001-11-03
US20050113578A1 (en) 2005-05-26
DE60103317T2 (de) 2005-06-16
CA2342571A1 (en) 2001-09-30
JP2001316393A (ja) 2001-11-13
CZ20011194A3 (cs) 2002-02-13
YU23301A (sh) 2003-04-30
KR100435128B1 (ko) 2004-06-09
ATE267204T1 (de) 2004-06-15
US20030114670A1 (en) 2003-06-19
DK1138685T3 (da) 2004-08-09
TR200401359T4 (tr) 2004-08-23
US20020077478A1 (en) 2002-06-20
US6844441B2 (en) 2005-01-18
AR033812A1 (es) 2004-01-07
KR100481603B1 (ko) 2005-04-08
AU3334801A (en) 2001-12-13
SI1138685T1 (en) 2004-12-31
CN1320596A (zh) 2001-11-07
ID29728A (id) 2001-10-04
EP1138685A3 (en) 2003-04-02
RU2223956C2 (ru) 2004-02-20
US6518431B2 (en) 2003-02-11
PL346805A1 (en) 2001-10-08
HK1038019A1 (en) 2002-03-01
TW555761B (en) 2003-10-01
AU782272B2 (en) 2005-07-14
HU0101332D0 (en) 2001-06-28
DE60103317D1 (de) 2004-06-24
HUP0101332A3 (en) 2004-07-28
ZA200102538B (en) 2002-09-30
EP1138685B1 (en) 2004-05-19
US20040133005A1 (en) 2004-07-08
US6670480B2 (en) 2003-12-30

Similar Documents

Publication Publication Date Title
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
BR0214870A (pt) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas e aplicação das mesmas
BR0208741A (pt) Derivados de piperidina
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
BRPI0413973A (pt) compostos
BRPI9917739B8 (pt) composto intermediário na preparação de inibidores de cox-2
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
ES2243579T3 (es) Derivados de pirazolopirideno.
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0412843A (pt) lactamas substituìdas e uso das mesmas como agentes anticáncer
BR0213481A (pt) Sondas
BRPI0411308A8 (pt) Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
BR9911250A (pt) Processo para preparação de compostos
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR0007982A (pt) Processo para a preparação de um composto, e,composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.